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Abstract
Background: Epidemiological studies have reported associations between reduced cardiovascular
disease and diets rich in tomato and/or lycopene. Intervention studies have shown that lycopene-
containing foods may reduce cholesterol levels and lipid peroxidation, factors implicated in the
initiation of cardiovascular disease. The objective of this study was to determine whether
consumption of lycopene rich foods conferred cardiovascular protection to middle-aged adults as
indicated by plasma lipid concentrations and measures of ex vivo antioxidants.
Methods: Ten healthy men and women consumed a low lycopene diet with no added lycopene
(control treatment) or supplemented with watermelon or tomato juice each containing 20 mg
lycopene. Subjects consumed each treatment for three weeks in a crossover design. Plasma,
collected weekly was analyzed for total cholesterol, high density lipoprotein cholesterol (HDL-C)
and triglyceride concentrations and for the antioxidant biomarkers of malondialdehyde formation
products (MDA), plasma glutathione peroxidase (GPX) and ferric reducing ability of plasma (FRAP).
Data were analyzed using Proc Mixed Procedure and associations between antioxidant and lipid
measures were identified by Pearson's product moment correlation analysis.
Results: Compared to the control diet, the lycopene-containing foods did not affect plasma lipid
concentrations or antioxidant biomarkers. Women had higher total cholesterol, HDL-C and
triglyceride concentrations than did the men. Total cholesterol was positively correlated to MDA
and FRAP while HDL-C was positively correlated to MDA and GPX. GPX was negatively
correlated to triglyceride concentration.
Conclusions: The inclusion of watermelon or tomato juice containing 20 mg lycopene did not
affect plasma lipid concentrations or antioxidant status of healthy subjects. However, plasma
cholesterol levels impacted the results of MDA and FRAP antioxidant tests.
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Watermelons and tomatoes are good sources of the caro-
tenoid lycopene [1,2]. However, bioavailability of lyco-
pene is not directly related to plant content, and depends
in a large part upon plant matrix effects. In tomatoes, heat
processing and homogenization breaks protein-caroten-
oid complexes, releases lycopene from cell wall linkages
and improves human uptake of this compound [3-6],
while heat processing is not necessary for adequate uptake
of lycopene from watermelon juice [7]. Extracts of both
foods exhibit antioxidant activity in vitro and function is
attributed to lycopene since isolated lycopene demon-
strates strong oxygen and peroxy radical scavenging prop-
erties [8-10].
Recent epidemiological studies have linked reductions in
risks of cardiovascular disease with diets rich in lycopene
containing foods. These reductions in risk have been pri-
marily attributed to the antioxidant properties of lyco-
pene [11,12]. Improved antioxidant parameters of
lymphocytes have been reported in clinical trials that sup-
plemented diets with 16.5 mg and 40 mg /day of lycopene
from tomato puree and tomato juice, respectively [13,14].
Other clinical trials have shown reductions in low-density
lipoprotein (LDL) oxidation resulting from lycopene sup-
plementation [15-17]. LDL contains unsaturated fatty
acids and can be oxidized by free radicals and peroxidiz-
ing agents. Since lycopene is primarily attached to LDL in
plasma, it may protect against atherosclerosis through
inhibition of lipid peroxidation and foam cell production
[12,18].
Other studies have assessed response of plasma lipids to
lycopene-rich diets. In one study, six healthy men were
supplemented with 60 mg/day for three months with
tomato lycopene (LycoRed) with a 14% reduction in LDL-
C and no change in HDL-C [19]. Researchers concluded
that lycopene was involved in controlling cholesterol syn-
thesis and found the same results in a macrophage cell
study [19]. It is not known if other lycopene containing
foods can act ex vivo as antioxidants or alter cholesterol
levels.
The objectives of this study were to compare the ability of
two lycopene containing foods, tomato and watermelon
to provide cardiovascular protection to middle-aged
adults by measuring changes in cholesterol levels and
antioxidant ex vivo biomarkers.
Methods
Experimental Design
Samples for this study came from a larger study, which has
been reported in detail [7]. This study was a diet-control-
led, repeated measures crossover design with ten healthy
non-smoking subjects, five men (average age 49 years)
and five women (average age 51 years) recruited from the
Beltsville, MD area (Table 1). In addition to a base diet,
which provided 34% of energy from fat and minimal
amounts of lycopene, subjects were randomly assigned to
receive three dietary treatments for 3 weeks each: 1) con-
trol (no added lycopene); 2) 20.1 mg lycopene per day
from watermelon juice; and 3) 18.4 mg lycopene per day
from tomato juice. All subjects followed a low-lycopene
diet for two weeks before the first treatment and during
the four-week washout periods between treatments. Total
study duration was 19 weeks. During treatment periods,
all meals were prepared and consumed Monday through
Friday at the Beltsville Human Nutrition Research
Center's Human Studies Facility, and weekend meals were
packed for off-site consumption. Blood was drawn from
fasted subjects before treatment (the day before the start
of study and on the first day of the study), prior to treat-
ment and weekly during treatment. Plasma was separated
from whole blood by centrifugation and stored at -80°C
until analyzed for cholesterol and antioxidant activity.
Juice Treatments
Watermelon juice for the study was prepared at a pilot
plant at the USDA Citrus and Subtropical Products Labo-
ratory, Winter Haven, FL without heat treatment as previ-
ously described [7]. Canned commercial tomato juice
(Campbell's, Camden, NJ) was used for the tomato inter-
vention. Juices were analyzed for carotenoid content using
established extraction procedures with reversed phase
HPLC with photo diode array detector (Waters Corp,
Franklin, MA) [7]. For watermelon treatment, subjects
were given one bottle of juice (260 g each) at breakfast,
lunch and dinner, which provided daily totals of 20.1 mg
lycopene, 0.90 mg phytoene, 0.45 mg phytofluene and
2.5 mg beta carotene. The juice contained 94% trans lyco-
pene and 6% cis isomers, primarily 5-cis and 13-cis with
minimal amounts of other cis isomers [7]. For tomato
juice treatment, subjects were given one serving (122 g
each) at breakfast and dinner, which provided daily totals
of 18.4 mg lycopene, 2.1 mg phytoene, 1.1 mg phytoflu-
ene and 0.6 mg beta carotene with 89% of the lycopene as
trans lycopene and 10.8% cis isomers, primarily identified
as 5-cis, 9-cis, 13-cis, and 15-cis, and minimal amounts of
other cis isomers [7].
Table 1: Description of human clinical study participants.
Gender N Age (Range) yr BMI (Range) Kg/m2
Men 5 49 (43–68) 26.3 (23.0–29.5)
Women 5 51 (35–63) 29.1 (23.5–34.5)Page 2 of 7
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Plasma samples were thawed on ice for four hours then
mixed by vortexing, prior to preparing for assays. Serum
total cholesterol and triglyceride concentrations were
determined enzymatically using kits from Roche Diagnos-
tics (Sommerville, NJ). Serum HDL-cholesterol was deter-
mined by a direct method (Unimate HDL Direct ; Roche
Diagnostics, Indianapolis, IN) that utilizes the combined
action of polymers, polyanions, and detergent to solubi-
lize cholesterol from HDL but not from VLDL, LDL, and
chylomicrons as previously described [20]. Analysis was
performed on a Cobas-Fara II Clinical Analyzer
(Montclair, NJ) using commercially available calibrators
and quality control standards (Roche Diagnostics, Indian-
apolis, IN).
Plasma Glutathione Peroxidase Assay
Plasma from subjects was analyzed for plasma glutath-
ione peroxidase using an ELISA kit (OXIS Internatl., Port-
land, OR). Two replicates per sample of 20 µl of plasma
were diluted 1:25 with TRIS-HCl buffer then pippetted
into pre-coated polyclonal antibodies microplate wells
specific for human plasma glutathione peroxidase (GPX).
The amount of enzyme present was determined by reac-
tion with para-nitrophenyl-phosphate and was read using
a microplate reader at 405 nm (Elx 808 Ultra Microplate
Reader, Bio-Tek Instruments Inc., Winooski, VT). The con-
centration of plasma GPX was determined from a stand-
ard curve for each plate using five dilutions of GPX
standard.
Plasma lipid peroxidation
Malondialdehyde compounds were determined colori-
metrically using a commercial kit specific for measuring
free and total malondialdehyde compounds (OXIS Inter-
natl., Portland, OR). Two replicates per sample of 210 µl
of plasma were added to each test tube with 11 µl of 500
mM butylated hydroxytoluene and 5.3 µl of concentrated
hydrochloric acid. Tubes were capped, mixed then incu-
bated at 60°C for 80 minutes, cooled to room tempera-
ture and 680 µl of N-methyl-2-phenylindole in
acetonitrile was added. Then tubes were mixed, and cen-
trifuged at 13,000 g for 5 minutes. New tubes were pre-
pared and 660 µl of clear supernatant was added with 115
µl of concentrated HCl. Tubes were capped, mixed and
incubated at 45°C for 60 minutes. Samples were centri-
fuged at 13,000 g for 5 min and the supernatant was read
on a spectrophometer at 575 nm. Concentration of sam-
ples was determined using a five point standard curve.
Ferric reducing ability of plasma assay
This assay was conducted according to previously pub-
lished methods [1]. In brief, three reagents were used: 1)
sodium acetate, acetic acid buffer (pH 3.6); 2)10 mmol/L
solution of 2, 4,6-tripyridyl-s-triazine in a 40 mmol/L
solution of hydrochloric acid (Sigma, St. Louis, MO); and
3) 20 mmol/L solution of ferric chloride hexahydrate pre-
pared in double deionized water. The FRAP reagent was
prepared daily with 25 ml of reagent one, 2.5 ml reagent
two and three that were heated to 37°C before using [21].
The assay was conducted with 10 uL of plasma that was
diluted with 30 µl of ddi water. Sample was added to rea-
gent in cuvettes with an autosampler and then read on a
COBAS FARA II spectrofluorometric centrifugal analyzer
(Roche, Montclair, NJ) at 593 nm at four minutes. FRAP
values were determined from a five point curve using a
trolox (vitamin E analog) standard. Standard curves were
run after every 90 samples.
Experimental procedures for the clinical trial were
approved by the Institutional Review Board at the Johns
Hopkins University Bloomberg School of Hygiene and
Public Health; subjects gave their written informed con-
sent to participate. The plasma cholesterol and antioxi-
dant studies were approved by the Institutional Review
Board at Oklahoma State University, Stillwater, OK. Data
were analyzed using Proc Mixed Procedure and mean sep-
aration was performed using LSMEANS, correlation anal-
ysis was performed using Spearman's Correlation
Coefficient Analysis (SAS Statistical Analysis Software,
version 8.2, SAS Institute, Cary, NC).
Results
Because there were significant four way interactions with
gender × intervention period × treatment × weeks with
MDA, FRAP, GPX and cholesterol analysis, trends by treat-
ment, intervention period or week of treatment were not
seen. Supplementing the diet with 20 mg/day of lycopene
of either food did not change the plasma antioxidant sta-
tus of the subjects and values ranged from 0.66–2.20,
540–1094, and 1296–2596 :mol/L for MDA, FRAP and
GPX respectively. These levels are similar to levels
reported for healthy subjects in other studie [22,23].
Intervention with 20 mg of lycopene to the diet of subjects
did not alter their total cholesterol, HDL-C or triglyceride
status. However, there were gender differences and the
women had higher average levels of plasma triglycerides,
total cholesterol and HDL-C than men (Figure 1). The
higher cholesterol levels for women compared to men in
this study were not unusual since women in this age range
often have higher cholesterol levels than men, a phenom-
enon related to decreased estrogen production [24,25]. In
this study, menopausal information was not recorded.
There was a significant positive correlation between each
pair of total cholesterol and MDA and MDA and FRAP
and between HDL-C and MDA and HDL-C and GPX. A
significant negative correlation was found between trig-
lycerides and GPX (Table 2).Page 3 of 7
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tions and antioxidant analysis, a preliminary analysis of
data was conducted to determine if cholesterol levels
impacted antioxidant results. Subjects were separated into
two groups based upon baseline concentrations of plasma
triglycerides, total cholesterol and LDL-C above or below
200, 180 and 160, respectively. Five subjects, two men
and three women, fit the criteria of moderately hypercho-
lesterolemic (Table 3).
Analyses showed an interaction of cholesterol level ×
treatment period × treatment factor for MDA and FRAP
analysis. Higher MDA and FRAP levels were found in the
group having higher cholesterol levels compared to the
other group (Table 4). No trend with cholesterol level and
glutathione peroxidase was found.
Discussion
We found no improvement in the antioxidant status of
healthy middle-aged adults supplemented with two lyco-
pene-containing foods. In previous antioxidant studies,
reduced lipid peroxidation was reported in subjects sup-
plemented from one to four weeks with 5 to 45 mg lyco-
pene containing tomato products [15,16,23,26].
However, in each of these studies, the diet was not con-
trolled. When healthy elderly subjects in a diet controlled
study were supplemented with 13.3 mg of tomato lyco-
pene (LycoRed) for 12 weeks, lycopene intervention did
not significantly change LDL oxidation, as measured by
the rate of conjugated diene production [27].
The reports from lycopene intervention studies that meas-
ured FRAP activity are not in agreement. One study
reported improvement in FRAP levels of plasma in sub-
jects supplemented with tomato juice and olive oil [28],
while two other tomato juice intervention studies
reported no improvement in plasma antioxidant levels
after lycopene supplementation as measured by Trolox
equivalent antioxidant capacity (TEAC), radical trapping
antioxidant parameter assay (TRAP), and FRAP [3,23].
Researchers in one study found that the FRAP assay was
more accurate when measuring the antioxidant activity of
water-soluble antioxidants [23]. They thought full expres-
sion of the antioxidant activity was not identified from
lycopene in this assay since it is a lipophyllic compound.
Curiously, both watermelon and tomato contain other
water-soluble compounds that are reported to have anti-
oxidant activity that reacts in vitro in the FRAP assay
[9,29]. In this study, contribution of these water-soluble
compounds in changes in plasma FRAP activity with
either food intervention compared to the control was not
found.
Unlike a previous report by Fuhrman et al., neither lyco-
pene intervention with watermelon nor tomato affected
cholesterol levels [19]. Differences in results may have
been due to lycopene dosage level. In that study [19] the
subjects were supplemented with 60 mg/day for three
months, however diet was not controlled.
Fruits and vegetables are excellent sources of antioxidant
compounds and the average American consumes only 1.5
and 3.1 servings per day [45]. In many of the studies
where antioxidant protection with lycopene containing
foods was reported, subjects consumed their normal diet
that may or may not have met the recommended servings
of fruits and vegetables [13,23,26,31,32]. Increasing fruit
and vegetable consumption to 12 servings per day com-
pared to 5.8 servings, without the addition of other diet
Mean plasma total cholesterol, triglycerides, and high density lipoprotein (HDL) l (m /dl) of 5 men and 5 women supplemented for 3 week with no lycope e (co -tr l), 20 mg lycopene fr m wat me on juice a d 20 mg lyco-pene fro  tomato juiceFigu e 1
Mean plasma total cholesterol, triglycerides, and high density 
lipoprotein (HDL) cholesterol (mg/dl) of 5 men and 5 
women supplemented for 3 week with no lycopene (con-
trol), 20 mg lycopene from watermelon juice and 20 mg lyco-
pene from tomato juice. *Represents significance p < 0.05.
Table 2: Spearman's Correlation Coefficients between 
antioxidant tests of malondialdehyde (MDA) ferric reducing 
ability of plasma (FRAP), and plasma glutathione peroxidase 
(GPX) and cholesterol measurements.
Variable MDA FRAP GPX
Total cholesterol 0.547** 0.325** 0.003
HDL-C 0.563** 0.059 0.294**
Triglycerides 0.219 0.037 -0.229*
MDA . 0.474** 0.180
FRAP 0.474** . 0.077
Correlations significant at the 0.05* and 0.01** level.Page 4 of 7
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damage (8-hydroxydeoxyguanosine) by 32% [33]. In a
controlled trial where subjects were supplemented with
tomato juice but restricted in total fruit and vegetable
consumption and exposed to low levels of ozone,
researchers found reduced DNA strand breaks compared
to placebo controls [34]. Because this study controlled for
other phytochemical containing fruits and vegetables, the
DNA protection was attributed to tomato juice phyto-
chemicals [34].
The positive correlation between total cholesterol and
MDA antioxidant analysis has been reported in studies
with hypercholesterolemic subjects compared to normoc-
holesterolemic subjects [35,36]. The MDA assay measures
lipid peroxidation products, and a higher level of lipids
available to react with peroxidizing agents results in
higher MDA values [36,37].
The trend correlating higher FRAP with higher cholesterol
levels has not been previously reported. The significance
of this trend is speculative, since the FRAP assay measures
the oxidation and reduction potential of compounds
based on the reduction of the ferric to ferrous iron [38],
lipid peroxidation products may have contributed to the
oxidation/reduction potential of the reaction.
Conclusions
Long-term supplementation studies where diet is control-
led will probably be necessary to identify the benefits pro-
vided by lycopene. There may be real health benefits
associated with lycopene especially since it is stored in
various tissues and exhibits strong antioxidant activity in
vitro [8,10,39,40]. Also the body of epidemiological evi-
dence points to the protection provided against cardiovas-
cular disease and some cancers with lycopene containing
foods [11,12,41,42]. Recent cancer intervention studies
have reported beneficial effects on prostate cancer from
lycopene food supplementation [43,44]. The health ben-
efits associated with diets providing lycopene are most
likely long-term. Therefore, the findings of the present
study should not be interpreted as a lack of health benefits
from regular consumption of lycopene-rich foods.
The interaction between cholesterol levels and antioxi-
dant values needs more research. Contradictory findings
Table 3: Separation of subjects by baseline cholesterol levels from a watermelon and tomato juice lycopene intervention study, n = 5 
for each group.
Cholesterol Group Total Cholesterol mg/dl Triglycerides mg/dl HDL-Cmg/dl
1 229.3 ± 4.9 190.9 ± 12.8 59.1 ± 2.9
2 176.6 ± 2.5 129.7 ± 5.2 46.9 ± 2.1
Data represents mean ± SE
Table 4: Total, triglyceride, high density lipoprotein (HDL-C cholesterol and antioxidant analysis of malondialdehyde (MDA), 
glutathione peroxidase (GPX) and ferric reducing ability of of plasma (FRAP) after 4 week lycopene depletion and three weeks of 
intervention with watermelon and tomato juice (20 mg lycopene/day). Subjects were separated into 2 groups based upon cholesterol 
levels (see Table 3).
Cholesterol 
Group
Analysis Depletion SE Control SE Watermelon SE Tomato SE
Total Cholesterol (mg/dl) 220.9 ± 9.5 223.4 ± 7.9 224.6 ± 8.2 233.6 ± 6.2
Triglycerides (mg/dl) 185.9 ± 16.9 181.7 ± 16.9 198.9 ± 18.3 174.7 ± 15.6
1 HDL-C (mg/dl) 56.9 ± 5.15 58.65 ± 4.31 58.00 ± 5.96 59.38 ± 4.55
MDA (umol/L) 1.21 ± 0.11 1.12 ± 0.11 1.15 ± 0.12 1.37 ± 0.11
GPX (umol/L) 2728 ± 219 2728 ± 222 2263 ± 169 2574 ± 187
FRAP (umol/L) 831.6 ± 24.9 871.7 ± 26.7 900.9 ± 25.2 861.6 ± 23.4
Total Cholesterol (mg/dl) 182.6 ± 4.2 173.3 ± 3.3 186.1 ± 6.4 173.1 ± 2.8
Triglycerides (mg/dl) 129.4 ± 8.3 128.7 ± 7.6 189.4 ± 4.9 135.4 ± 10.7
2 HDL-C (mg/dl) 42.5 ± 3.3 43.6 ± 2.8 44.7 ± 4.0 38.3 ± 2.8
MDA (umol/L) 0.53 ± 0.03 0.56 ± 0.04 0.48 ± 0.04 0.54 ± 0.03
GPX (umol/L) 2129 ± 151 2111 ± 154 2292 ± 168 2229 ± 160
FRAP (umol/L) 743.9 ± 33.6 762.9 ± 30.7 780.9 ± 32.4 756.7 ± 36.0Page 5 of 7
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